Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,354.80
-11.8 (-0.5%)
BSENSE

Jun 25, 03:30 PM

BSE+NSE Vol: 1.26 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
-0.5%
0.14%
1W
3.91%
-0.46%
1M
2.38%
0.1%
YTD
-4.8%
-7.94%
1Y
-27.74%
-4.71%
3Y
66.45%
28.88%
5Y
55.45%
51.67%
10Y
35.52%
197.41%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.42%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.43%
2.50%
3.93%
6 Months
-5.31%
2.30%
-3.01%
1 Year
-27.74%
1.70%
-26.04%
2 Years
-10.86%
2.73%
-8.13%
3 Years
66.45%
7.24%
73.69%
4 Years
57.01%
8.79%
65.8%
5 Years
55.45%
11.99%
67.44%

Latest dividend: 57 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

3
Quartile
quartile-3
QTD
3.14%
4
Quartile
quartile-4
Dec-Mar
-7.71%
4
Quartile
quartile-4
Sep-Dec
-7%
4
Quartile
quartile-4
YTD
-28.68%
1
Quartile
quartile-1
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
3.14%
2
Quartile
quartile-2
Dec-Mar
-7.71%
3
Quartile
quartile-3
Sep-Dec
-7%
4
Quartile
quartile-4
YTD
-28.68%
1
Quartile
quartile-1
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
3.14%
2
Quartile
quartile-2
Dec-Mar
-7.71%
4
Quartile
quartile-4
Sep-Dec
-7%
4
Quartile
quartile-4
YTD
-28.68%
2
Quartile
quartile-2
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available